Showing results (51-60 of 247) with videos related to
Sort By:
Pageof 25
The Prostate|February 17, 2006
Vaccination of hormone-refractory prostate cancer patients with peptide cocktail-loaded dendritic cells: results of a phase I clinical trialSusanne Fuessel, Axel Meye, Marc Schmitz, et al.Biochemical and Biophysical Research Communications|August 18, 2004
D-GPCR: a novel putative G protein-coupled receptor overexpressed in prostate cancer and prostateBernd Weigle, Susanne Fuessel, Reinhard Ebner, et al.BMC Cancer|November 25, 2017
An orthotopic xenograft model for high-risk non-muscle invasive bladder cancer in mice: influence of mouse strain, tumor cell count, dwell time and bladder pretreatmentDoreen Huebner, Christiane Rieger, Ralf Bergmann, et al.Methods in Molecular Biology (Clifton, N.J.)|March 29, 2008
Telomerase inhibition by synthetic nucleic acids and chemosensitization in human bladder cancer cell linesKai Kraemer, Susanne Fuessel, Axel MeyeJournal of Cellular Biochemistry|February 24, 2011
Expression profile of WNT molecules in prostate cancer and its regulation by aminobisphosphonatesSylvia Thiele, Martina Rauner, Claudia Goettsch, et al.Medizinische Monatsschrift Fur Pharmazeuten|June 29, 2018
Prostate cancer: Basics on clinical appearance, diagnostics and treatmentChrister Groeben, Manfred P WirthDrugs & Aging|October 8, 2013
Locally advanced prostate cancer: optimal therapy in older patientsMichael Froehner, Manfred P WirthDrugs & Aging|January 22, 2003
Value of endocrine therapy for early and locally advanced prostate cancerManfred P Wirth, Michael FroehnerOncology|September 2, 2003
Adjuvant hormonal treatment for prostate cancer: the bicalutamide early prostate cancer programManfred P Wirth, Michael FroehnerBMC Cancer|September 4, 2014
High serum levels of Dickkopf-1 are associated with a poor prognosis in prostate cancer patientsTilman D Rachner, Stefanie Thiele, Andy Göbel, et al.Pageof 25